Does the implementation of an interferon-gamma release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers?
Sahni
Rajiv
R
Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA. sahnir@ccf.org
Miranda
Cyndee
C
Yen-Lieberman
Belinda
B
Tomford
J Walton
JW
Terpeluk
Paul
P
Quartey
Pearl
P
Johnson
Lucileia T
LT
Gordon
Steven M
SM
D000995:Antitubercular Agents / Q000627:therapeutic use; D006282:Health Personnel; D006801:Humans; D007371:Interferon-gamma / Q000097:blood*; D007538:Isoniazid / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000276:immunology; D009820:Ohio; D010342:Patient Acceptance of Health Care; D011933:Reagent Kits, Diagnostic / Q000706:statistics & numerical data*; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis / Q000517:prevention & control
D000995:Antitubercular Agents; D011933:Reagent Kits, Diagnostic; D007371:Interferon-gamma; D007538:Isoniazid